Vendor, Saint Charles, MO
Eurofins Discovery Services North America, LLC
UEI HF4LCAU68M93, CAGE 736G3
33 awards and $3,507,281 obligated between January 9, 2024 and September 8, 2026, 64% under full and open competition, against 2.8 offers on average where reported. 2 of the awards trace back to a SAM.gov solicitation on this site.
Sells to
Awarding agencies by dollars.
| National Institutes of Health | $1,977,068 |
| Environmental Protection Agency | $1,192,498 |
| Food and Drug Administration | $323,659 |
| Department of Veterans Affairs | $14,056 |
Industries
NAICS on the awards, by dollars.
| Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)NAICS 541715 | $2,010,419 |
| Research and Development in Biotechnology (except Nanobiotechnology)NAICS 541714 | $1,455,420 |
| Testing Laboratories and ServicesNAICS 541380 | $41,443 |
How it wins
Awards by competition, set-aside and type.
| Full and Open Competition | 21 |
| Full and Open Competition After Exclusion of Sources | 6 |
| Competed Under SAP | 2 |
| Not Competed | 2 |
| Small Business Set Aside - Total | 2 |
| Delivery Order | 22 |
| Purchase Order | 6 |
Hear when Eurofins Discovery Services North America, LLC wins an award and when a contract it holds is about to end.Follow it
Contracts ending soon
Contracts Eurofins Discovery Services North America, LLC holds whose performance ends in the next 19 months, by published end date. Each one is a recompete to prepare for.
- Ending
- 5
- Obligated so far
- $1,613,840
- Soonest
- November 30, 2026
The 5 contracts, the office behind each one and the dates are in the workspace. See them
Competes with
Vendors selling research and development in the physical, engineering, and life sciences (except nanotechnology and biotechnology) to National Institutes of Health, by dollars.
| Leidos Biomedical Research Inc.Frederick, MD | $2,186,369,442 |
| Westat, Inc.Rockville, MD | $760,724,225 |
| Technical Resources International, Inc.Bethesda, MD | $196,391,189 |
| Duke UniversityDurham, NC | $158,758,507 |
| MriglobalKansas City, MO | $117,921,746 |
| The Johns Hopkins UniversityBaltimore, MD | $100,932,043 |
Solicitations it won
SAM.gov opportunities whose award USAspending attributes to this vendor.
- Dose Response with targets >75% activity in SafetyScreen CNS Panel
National Institutes of Health, National Institutes of Health Nida
Combined synopsis and solicitationNAICS 541380St. Charles, MO75N95024Q00157Posted Feb 21, 20242 publications
Awards
Every award in the window, by dollars obligated.
| Contract | Awarding office | Described as | Obligated |
|---|---|---|---|
| 75N93026F00001Delivery Order, February 20, 2026, Full and Open Competition | National Institutes of Health NiaidNational Institutes of Health | Interventional Agents Safety and Pharmacokinetic ServicesNAICS 541714, PSC AN11 | $627,922 |
| 75N93024F00002Delivery Order, September 19, 2024, Full and Open Competition, 1 offers | National Institutes of Health NiaidNational Institutes of Health | Nonclinical Services for the Development of Interventional Agents for Infectious DiseasesNAICS 541714, PSC AN11 | $443,794 |
| 68HERC25F0325Delivery Order, August 21, 2025, Full and Open Competition | Cincinnati Acquisition Div (Cad)Environmental Protection Agency | R799 - Rescreening the Core Reference Chemicals in Er and Ar Binding Assays at Eurofins Internal Task Order 10NAICS 541715, PSC R799 | $383,715 |
| 75N95024F00001Delivery Order, April 11, 2024, Full and Open Competition After Exclusion of Sources | National Institutes of Health NidaNational Institutes of Health | Receptor Profiles. Eurofins Panlabs INC. N01DA-23-8937. Pop April 12, 2024 to April 11, 2025.NAICS 541715, PSC AN11 | $300,609 |
| 68HERC25F0012Delivery Order, December 12, 2024, Full and Open Competition | Cincinnati Acquisition Div (Cad)Environmental Protection Agency | Eurofins 68herc22d0008 Internal Task Order 8, Funded by Ocspp/Oppt Replaces Pr-Ord-24-02044 New Task Order, See Attached Order Sheet 12/12/2NAICS 541715, PSC R799 | $282,571 |
| 68HERC25F0084Delivery Order, December 16, 2024, Full and Open Competition | Cincinnati Acquisition Div (Cad)Environmental Protection Agency | Eurofins 68herc22d0008 Internal Task Order 9 This to Is Funded by Ocspp/Oppt New Task Order, See Attached Order Sheet Period of Performance NAICS 541715, PSC R799 | $276,709 |
| 68HERC25F0014Delivery Order, December 16, 2024, Full and Open Competition | Cincinnati Acquisition Div (Cad)Environmental Protection Agency | Eurofins 68herc24d0008 Initiation of Internal to 7 to Acquire Assays Per the Order Details.NAICS 541715, PSC R799 | $250,055 |
| 75N95025F00002Delivery Order, August 28, 2025, Full and Open Competition After Exclusion of Sources | National Institutes of Health NidaNational Institutes of Health | Receptor Profile Screening. N01DA-23-8937. Pop September 21, 2025 to September 20, 2026.NAICS 541715, PSC AN11 | $249,094 |
| 75F40123F19001Delivery Order, May 30, 2024, Full and Open Competition | FDA Office of Acq Grant SVCSFood and Drug Administration | Non-Clinical and Laboratory SupportNAICS 541714, PSC AN42 | $238,886 |
| 75N93022F00001Delivery Order, September 6, 2024, Full and Open Competition, 1 offers | National Institutes of Health NiaidNational Institutes of Health | Preclinical Models of Infectious DiseasesNAICS 541714, PSC AN11 | $216,610 |
| 75N98026F00001Delivery Order, August 26, 2026, Full and Open Competition After Exclusion of Sources | National Institutes of Health OlaoNational Institutes of Health | Receptor Profile Screening. N01DA-23-8937. Pop September 1, 2026 to August 31, 2027. Dap-Ncap-00000159NAICS 541715, PSC AN11 | $136,499 |
| 75N95025F00001Delivery Order, June 24, 2025, Full and Open Competition After Exclusion of Sources | National Institutes of Health NidaNational Institutes of Health | Receptor Profile Screening. N01DA-23-8937. Pop June 25, 2025 to June 24, 2026.NAICS 541715, PSC AN11 | $132,772 |
| 75N93024F00001Delivery Order, September 13, 2024, Full and Open Competition, 4 offers | National Institutes of Health NiaidNational Institutes of Health | Lead Identification, Development, Chemistry and Synthesis ServicesNAICS 541714, PSC AN11 | $67,783 |
| 75F40124P00504Purchase Order, September 19, 2024, Competed Under SAP, 2 offers | FDA Office of Acq Grant SVCSFood and Drug Administration | Dose Response Analyses of Montelukast Targets.NAICS 541714, PSC B504 | $46,134 |
| 75F40124F19002Delivery Order, July 25, 2024, Full and Open Competition | FDA Office of Acq Grant SVCSFood and Drug Administration | To Predict the Safety of Food Chemicals by in Vitro Screening on a Panel of Biological Targets in Vitro.NAICS 541714, PSC AN42 | $38,640 |
| 75N95024P00586Purchase Order, September 9, 2024, Competed Under SAP, 1 offers | National Institutes of Health NidaNational Institutes of Health | Eurofins Discoverx Products LLC:1348767 [24-007264]NAICS 541380, PSC Q301 | $20,217 |
| 75N95024P00154Purchase Order, April 3, 2024, Not Competed Under SAP, 1 offersSolicitation | National Institutes of Health NidaNational Institutes of Health | Dose Response with Targets >75% Activity in Safetyscreen CNS PanelNAICS 541380, PSC Q301 | $13,228 |
| 36C24E24P0043Purchase Order, April 18, 2024, Not Competed, 1 offers | Rpo EastDepartment of Veterans Affairs | IN-VITRO Safety and Toxicity Drug Testing ServicesNAICS 541380, PSC AJ11 | $7,998 |
| 36C24224P0536Purchase Order, January 19, 2024, Not Competed, 1 offers | 242-Network Contract Office 02Department of Veterans Affairs | Quantitative Bioanalysis of Rat PlasmaNAICS 541714, PSC AJ11 | $6,058 |
| 68HERC22D0008November 26, 2024, Full and Open Competition, 1 offers | Cincinnati Acquisition Div (Cad)Environmental Protection Agency | The Purpose of This Modification Is to Change the CL-CORNAICS 541715, PSC R799 | $0 |
| 75F40123D00034December 10, 2024, Full and Open Competition, 1 offers | FDA Office of Acq Grant SVCSFood and Drug Administration | Research and Development Services StudiesNAICS 541714, PSC AN42 | $0 |
| 75N93025D00011September 15, 2025, Full and Open Competition, 17 offers | National Institutes of Health NiaidNational Institutes of Health | Interventional Agents Safety and Pharmacokinetic ServicesNAICS 541714, PSC AN11 | $0 |
| 75N95019D00029April 28, 2025, Full and Open Competition, 13 offers | National Institutes of Health NidaNational Institutes of Health | Eoi::implementing the Presidents Department of Government Efficiency Cost Efficiency Initiative (March 19, 2025)::EOI Notice of Termination NAICS 541715, PSC AN11 | $0 |
| 75N95023D00021January 9, 2024, Full and Open Competition After Exclusion of Sources, 1 offers | National Institutes of Health NidaNational Institutes of Health | Receptor Binding and Predictive Toxicology. Eurofins Panlabs INC. N01DA-23-8937. Pop September 26, 2023 to September 25, 2028.NAICS 541715, PSC AN11 | $0 |
| 75N95C22P00008Purchase Order, June 16, 2026, Not Competed Under SAP, 1 offers | National Institutes of Health NcatsNational Institutes of Health | FY26 Udo Initiative - Deobligate Excess Funds-Lab Testing Service: D2L and D3 Human Dopamine Radioligand Binding AssayNAICS 541380, PSC Q301 | -$0 |
| 68HERC24F0028Delivery Order, March 21, 2024, Full and Open Competition | Cincinnati Acquisition Div (Cad)Environmental Protection Agency | The Purpose of This Contract Action Is to Modify Confirmatory Assays and Safety Pharmacology Internal Task Order 6 Against Eurofins IDIQ 68hNAICS 541715, PSC R799 | -$551 |
| 75N95023F00001Delivery Order, June 3, 2026, Full and Open Competition After Exclusion of Sources | National Institutes of Health NidaNational Institutes of Health | Task Order 01. Receptor Binding and Predictive Toxicology. Eurofins Panlabs INC. N01DA-23-8937. Pop September 26, 2023 to September 25, 2024NAICS 541715, PSC AN11 | -$1,053 |
| 75N95019F00089Delivery Order, May 14, 2024, Full and Open Competition | National Institutes of Health NidaNational Institutes of Health | FY19: Receptor Profiling and Predictive Toxicology. June 21, 2019 - June 20, 2020. N01DA-18-8937.NAICS 541714, PSC AN11 | -$6,782 |
| 75N95020F00001Delivery Order, July 7, 2025, Full and Open Competition | National Institutes of Health NidaNational Institutes of Health | Task Order No. 75N95020F00001 (Receptor Profiles) IDIQ Contract No. Hhsn271201800024i for Work as Described for Nida Contract Task Order ParNAICS 541714, PSC AN11 | -$17,753 |
| 75N93023F00001Delivery Order, March 20, 2024, Full and Open Competition, 1 offers | National Institutes of Health NiaidNational Institutes of Health | Non-Clinical ServicesNAICS 541714, PSC AN11 | -$41,000 |
| 75N93021F00003Delivery Order, July 28, 2026, Full and Open Competition, 1 offers | National Institutes of Health NiaidNational Institutes of Health | To Administrate De-Obligate Unexpended and Expiring Fiscal Year 2021 Funding in Accordance with 31 U.S.C. Section 1552 (A), in Preparation fNAICS 541714, PSC AN11 | -$43,956 |
| 75N93021F00001Delivery Order, July 28, 2026, Full and Open Competition, 1 offers | National Institutes of Health NiaidNational Institutes of Health | To Administrate De-Obligate Unexpended and Expiring Fiscal Year 2021 Funding in Accordance with 31 U.S.C. Section 1552 (A), in Preparation fNAICS 541714, PSC AN11 | -$49,716 |
| 75N93021F00002Delivery Order, August 25, 2026, Full and Open Competition, 2 offers | National Institutes of Health NiaidNational Institutes of Health | To Administrate De-Obligate Unexpended and Expiring Fiscal Year 2021 Funding in Accordance with 31 U.S.C. Section 1552 (A), in Preparation fNAICS 541714, PSC AN11 | -$71,200 |
- Places of performance
- MissouriMarylandNew Jersey
- Product and service codes
- AN11 Health R&D Services; Health Care Services; Basic ResearchR799 Other Management Support ServicesAN42 Health R&D Services; Health Care - Other; Applied ResearchB504 Chemical/Biological Studies and AnalysisQ301 Reference Laboratory TestingAJ11 General Science And Technology R&D Services; General Science And Technology; Basic Research
- Transactions
- 59 across 33 awards